1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow TRL1068: new trials by email Literature Review of TRL1068 trials Research Report on TRL1068
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection TRL1068 (calpurbatug), a human monoclonal antibody, DAIR - Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee | Phase 2 | Active not recruiting | Trellis Bioscience LLC | 60 | 2025-04-08 | 2026-05-07 |
United States (1)